Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| naive B cell | 12 studies | 20% ± 4% | |
| B cell | 11 studies | 21% ± 4% | |
| plasma cell | 6 studies | 32% ± 5% | |
| memory B cell | 5 studies | 19% ± 2% | |
| plasmablast | 4 studies | 34% ± 18% | |
| ciliated cell | 4 studies | 21% ± 3% | |
| endothelial cell | 4 studies | 20% ± 4% | |
| regulatory T cell | 4 studies | 17% ± 1% | |
| plasmacytoid dendritic cell | 4 studies | 21% ± 4% | |
| epithelial cell | 3 studies | 27% ± 8% | |
| fibroblast | 3 studies | 20% ± 4% | |
| macrophage | 3 studies | 16% ± 1% | |
| dendritic cell | 3 studies | 29% ± 10% | |
| basal cell | 3 studies | 19% ± 2% | |
| astrocyte | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| stomach | 100% | 588.32 | 359 / 359 | 100% | 3.06 | 285 / 286 |
| esophagus | 100% | 534.03 | 1445 / 1445 | 99% | 3.14 | 182 / 183 |
| brain | 99% | 627.57 | 2628 / 2642 | 100% | 3.29 | 703 / 705 |
| lung | 100% | 661.55 | 577 / 578 | 99% | 2.73 | 1145 / 1155 |
| intestine | 100% | 744.20 | 966 / 966 | 99% | 2.95 | 520 / 527 |
| thymus | 100% | 810.26 | 653 / 653 | 98% | 3.09 | 593 / 605 |
| pancreas | 100% | 463.73 | 327 / 328 | 98% | 2.96 | 175 / 178 |
| breast | 100% | 680.67 | 459 / 459 | 97% | 3.11 | 1083 / 1118 |
| prostate | 100% | 669.02 | 245 / 245 | 96% | 2.47 | 481 / 502 |
| ovary | 100% | 787.51 | 180 / 180 | 96% | 2.35 | 411 / 430 |
| kidney | 100% | 581.76 | 89 / 89 | 95% | 2.72 | 859 / 901 |
| bladder | 100% | 687.10 | 21 / 21 | 95% | 2.46 | 478 / 504 |
| skin | 100% | 531.38 | 1808 / 1809 | 93% | 2.48 | 440 / 472 |
| adrenal gland | 100% | 711.22 | 258 / 258 | 90% | 3.13 | 207 / 230 |
| uterus | 100% | 708.51 | 170 / 170 | 89% | 1.94 | 409 / 459 |
| liver | 100% | 341.48 | 225 / 226 | 53% | 0.96 | 215 / 406 |
| adipose | 100% | 642.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 989.46 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 634.34 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 729.37 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 514.30 | 846 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 3.92 | 28 / 29 |
| peripheral blood | 96% | 742.37 | 890 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 1.59 | 40 / 45 |
| eye | 0% | 0 | 0 / 0 | 88% | 2.04 | 70 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0060322 | Biological process | head development |
| GO_0044782 | Biological process | cilium organization |
| GO_2000369 | Biological process | regulation of clathrin-dependent endocytosis |
| GO_0005905 | Cellular component | clathrin-coated pit |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CCDC32 |
| Protein name | Coiled-coil domain-containing protein 32 Coiled-coil domain containing 32 |
| Synonyms | C15orf57 hCG_1999239 |
| Description | FUNCTION: Regulates clathrin-mediated endocytsois of cargos such as transferrin probably through the association and modulation of adaptor protein complex 2 (AP-2) . Has a role in ciliogenesis (By similarity). Required for proper cephalic and left/right axis development . . |
| Accessions | ENST00000560305.5 ENST00000558750.5 [Q9BV29-2] H0YLI5 ENST00000558918.1 ENST00000416810.7 [Q9BV29-1] A0A8V8TLS2 H0YMC0 ENST00000558113.5 ENST00000559103.1 ENST00000698443.1 Q9BV29 ENST00000559291.5 [Q9BV29-1] ENST00000559153.5 [Q9BV29-1] ENST00000559911.5 ENST00000561011.5 [Q9BV29-3] H0YM19 ENST00000558871.1 [Q9BV29-3] H0YLN5 ENST00000358005.7 [Q9BV29-1] H0YN78 |